Zacks Investment Research on MSN
BioMarin Beats on Q3 Earnings, Seeks to Divest Hemophilia Gene Therapy
BioMarin Pharmaceutical BMRN reported third-quarter 2025 adjusted earnings per share (EPS) of 12 cents against the Zacks ...
Citizens JMP upgraded Spruce Biosciences (SPRB) to Outperform from Market Perform with a $254 price target The firm cites the company’s ...
Amicus Therapeutics (FOLD) remains a Buy, driven by strong product momentum and new assets. Read here for more investment ...
Australians with the extremely rare and life-threatening inherited disease, acid sphingomyelinase deficiency (ASMD) will now have free access to a ...
Overall and event-free survival of 100 and 95%, respectively, seen with autologous CD34+ hematopoietic stem-cell lentiviral gene therapy.
Pancreatitis can cause nutrient deficiencies. A well-balanced diet can help relieve symptoms such as inflammation and pain, as well as improve digestion.
1 Lysosomal & Rare Disorders Research & Treatment Center, Fairfax, VA, United States 2 Takeda Pharmaceuticals USA, Inc., Lexington, MA, United States Objective: To evaluate the effectiveness and ...
A study published in Science reveals a cellular mechanism involved in the inheritance of genetic mutations. The study also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback